Related Experiment Video
Updated: Jul 9, 2026
Pre-clinical Model of Cardiac Donation after Circulatory Death
Published on: August 2, 2019
Differential Effects of Brain Death and Circulatory Death on Myocardial Integrity and Transplant Outcomes
Chang Kon Kim1, Shaanali Mukadam1, Devendra K Agrawal1
1Department of Translational Research, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, California 91766, USA.
Insights
Donor cause of death, whether brain death or circulatory death, impacts heart transplant outcomes. Understanding these differences aids in optimizing donor organ use and improving patient survival.
Area of Science:
- Cardiology
- Transplantation Immunology
- Regenerative Medicine
Background:
- Heart transplantation is limited by donor organ scarcity.
- Expanded criteria include donors after brain death (DBD) and circulatory death (DCD).
- Distinct pathophysiological changes occur in DBD and DCD donors, affecting graft quality.
Purpose of the Study:
- To analyze how donor death mechanism influences heart transplant outcomes.
- To explore mechanistic differences between DBD and DCD donor injury.
- To evaluate strategies for optimizing outcomes in heart transplantation.
Main Methods:
- Review of mechanistic underpinnings of DBD and DCD donor injury.
- Assessment of impact on post-transplant complications.
- Evaluation of emerging strategies like ex vivo perfusion and molecular monitoring.
Main Results:
- DBD donors experience systemic inflammation and endothelial dysfunction.
- DCD donors are prone to warm ischemia and reperfusion injury.
- Donor death mechanism differentially affects graft performance, rejection, and survival.
Conclusions:
- Donor physiology significantly impacts heart transplant success.
- Precision protocols integrating donor and recipient profiles are crucial.
- Optimizing graft utilization and patient outcomes requires tailored approaches.
Abstract:
Heart transplantation is the definitive treatment for end-stage heart failure, yet the persistent scarcity of donor organs has necessitated expanded criteria for donor selection, particularly the inclusion of donors after brain death (DBD) and circulatory death (DCD). These two mechanisms of donor death result in distinct pathophysiological alterations that impact myocardial viability, inflammatory activation, and immune recognition. DBD is characterized by a catecholamine surge, hormonal collapse, and systemic inflammation, contributing to endothelial dysfunction and immunologic priming. In contrast, DCD grafts are subjected to warm ischemia and reperfusion injury, elevating the risk of primary graft dysfunction and delayed recovery. These physiological differences may differentially influence graft performance, immunologic rejection, infection risk, and long-term survival. This review presents a detailed analysis of how the cause of donor death influences clinical outcomes in heart transplantation. It explores the mechanistic underpinnings of DBD- and DCD-associated injury, assesses their impact on post-transplant complications, and evaluates emerging strategies such as ex vivo perfusion, donor-derived cell-free DNA monitoring, and gene expression profiling. Additionally, it discusses how donor physiology intersects with recipient characteristics, the selective use of heterotopic transplantation, and evolving approaches in immunosuppression and risk stratification. These insights support the development of precision-guided protocols that integrate donor and recipient profiles to optimize graft utilization and improve outcomes.
